We just received data on a new analyst forecast for $VRTX. Geoff Meacham from Citigroup set a price target of 575.0 for VRTX.
To track analyst ratings and price targets for $VRTX, check out Quiver Quantitative's $VRTX forecast page.
$VRTX Price Targets
Multiple analysts have issued price targets for $VRTX recently. We have seen 17 analysts offer price targets for $VRTX in the last 6 months, with a median target of $478.0.
Here are some recent targets:
- Geoff Meacham from Citigroup set a target price of $575.0 on 10/02/2025
- David Risinger from Leerink Partners set a target price of $456.0 on 09/25/2025
- Liisa Bayko from Evercore ISI Group set a target price of $475.0 on 09/11/2025
- Whitney Ijem from Canaccord Genuity set a target price of $411.0 on 08/06/2025
- Mohit Bansal from Wells Fargo set a target price of $460.0 on 08/06/2025
- Debjit Chattopadhyay from Guggenheim set a target price of $546.0 on 08/06/2025
- Brian Abrahams from RBC Capital set a target price of $405.0 on 08/05/2025
$VRTX Congressional Stock Trading
Members of Congress have traded $VRTX stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $VRTX stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR purchased up to $15,000 on 08/07.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 06/11, 06/10.
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$VRTX Insider Trading Activity
$VRTX insiders have traded $VRTX stock on the open market 7 times in the past 6 months. Of those trades, 4 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $VRTX stock by insiders over the last 6 months:
- RESHMA KEWALRAMANI (CEO & President) has made 2 purchases buying 10,000 shares for an estimated $3,895,767 and 0 sales.
- BRUCE I SACHS has made 2 purchases buying 5,000 shares for an estimated $1,948,415 and 0 sales.
- SANGEETA N. BHATIA has made 0 purchases and 2 sales selling 666 shares for an estimated $305,203.
- DAVID ALTSHULER (EVP, Chief Scientific Officer) sold 52 shares for an estimated $22,083
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$VRTX Hedge Fund Activity
We have seen 686 institutional investors add shares of $VRTX stock to their portfolio, and 753 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS added 1,986,004 shares (+305.6%) to their portfolio in Q2 2025, for an estimated $884,168,980
- AMUNDI removed 1,965,643 shares (-63.4%) from their portfolio in Q2 2025, for an estimated $875,104,263
- JPMORGAN CHASE & CO removed 1,886,284 shares (-24.3%) from their portfolio in Q2 2025, for an estimated $839,773,636
- VICTORY CAPITAL MANAGEMENT INC added 1,861,279 shares (+633.3%) to their portfolio in Q2 2025, for an estimated $828,641,410
- CAPITAL RESEARCH GLOBAL INVESTORS added 1,571,947 shares (+10.8%) to their portfolio in Q2 2025, for an estimated $699,830,804
- FMR LLC removed 1,320,812 shares (-17.1%) from their portfolio in Q2 2025, for an estimated $588,025,502
- JENNISON ASSOCIATES LLC added 1,089,063 shares (+21.5%) to their portfolio in Q2 2025, for an estimated $484,850,847
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
